Literature DB >> 9114515

Development of HIV-1 protease expression methods using the T7 phage promoter system.

T Komai1, Y Ishikawa, R Yagi, H Suzuki-Sunagawa, T Nishigaki, H Handa.   

Abstract

New and simple human immunodeficiency virus type 1 (HIV-1) protease expression methods in Escherichia coli were developed using the T7 phage promoter system. In order to suppress leaky HIV-1 protease expression under the control of the T7 polymerase, two new methods were tested. One involved the introduction of supplementary T7 promoter regions into host cells [E. coli BL-21 (DE3)] containing the HIV-1 protease gene under the control of the T7 promoter. It was expected that the supplementary T7 promoter regions would compete with the HIV-1 protease expression vector for the T7 polymerase binding. The other involved the infection of late-log-phase cultures of E. coli JM109 harboring the same HIV-1 protease expression vector with the M13 phage expressing T7 polymerase. Both methods were effective, and transformants with the mature HIV-1 protease expression vector showed ten times higher HIV-1 protease activity than activities obtained with the autoprocessing vector. The expression systems described here are convenient and are also easily applicable for the expression of other proteins toxic for E. coli.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9114515     DOI: 10.1007/s002530050920

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  Optimizing HIV-1 protease production in Escherichia coli as fusion protein.

Authors:  Federica Volontè; Luciano Piubelli; Loredano Pollegioni
Journal:  Microb Cell Fact       Date:  2011-06-30       Impact factor: 5.328

2.  Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis.

Authors:  Keehwan Kwon; Jeremy Hasseman; Saeeda Latham; Carissa Grose; Yu Do; Robert D Fleischmann; Rembert Pieper; Scott N Peterson
Journal:  BMC Biochem       Date:  2011-05-05       Impact factor: 4.059

3.  Cloning and Expression of Soluble Recombinant HIV-1 CRF35 Protease-HP Thioredoxin Fusion Protein.

Authors:  Asaad Azarnezhad; Zohreh Sharifi; Rahmatollah Seyedabadi; Arshad Hosseini; Behrooz Johari; Mahsa Sobhani Fard
Journal:  Avicenna J Med Biotechnol       Date:  2016 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.